Security key
14888U101
CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)
CUSIP: 14888U101
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 123,180,519
- Total 13F shares
- 97,462,582
- Share change
- +1,754,517
- Total reported value
- $2,034,900,504
- Put/Call ratio
- 87%
- Price per share
- $20.87
- Number of holders
- 333
- Value change
- +$38,258,566
- Number of buys
- 181
- Number of sells
- 128
Report period
Q4 2024
Institutions
333
Top holders
10
CPRX full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
CATALYST PHARMACEUTICALS, INC. SEC filings
CATALYST PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 14888U101
Recent filing periods:
Top shareholders of CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| James E. Flynn |
13D/G
|
Deerfield Mgmt, L.P. |
2.6%
|
3,133,011
|
$74,033,050 | $0 | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
15%
|
19,017,491
|
$378,067,727 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.5%
|
8,040,978
|
$159,854,643 | — | 30 Sep 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
5.1%
|
6,229,634
|
$123,845,124 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
4.6%
|
5,685,330
|
$113,024,360 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.5%
|
3,018,789
|
$60,011,355 | — | 30 Sep 2024 | |
| Pacer Advisors, Inc. |
13F
|
Company |
2.3%
|
2,804,013
|
$55,743,778 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
2,664,424
|
$52,978,585 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.1%
|
2,526,016
|
$50,217,198 | — | 30 Sep 2024 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
2%
|
2,428,973
|
$48,287,983 | — | 30 Sep 2024 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
1.6%
|
2,021,105
|
$40,179,567 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.5%
|
1,823,274
|
$36,246,693 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.2%
|
1,472,253
|
$29,268,389 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.1%
|
1,383,800
|
$27,509,944 | — | 30 Sep 2024 | |
| Boston Partners |
13F
|
Company |
1%
|
1,275,267
|
$25,565,080 | — | 30 Sep 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1%
|
1,234,383
|
$24,540,000 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.95%
|
1,167,743
|
$23,214,731 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.92%
|
1,139,142
|
$22,646,142 | — | 30 Sep 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.86%
|
1,057,390
|
$21,020,913 | — | 30 Sep 2024 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.85%
|
1,041,416
|
$20,703,350 | — | 30 Sep 2024 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
0.77%
|
951,324
|
$18,912,000 | — | 30 Sep 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.76%
|
939,526
|
$18,677,777 | — | 30 Sep 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.7%
|
860,934
|
$17,115,368 | — | 30 Sep 2024 | |
| Mesirow Institutional Investment Management, Inc. |
13F
|
Company |
0.65%
|
800,798
|
$15,919,864 | — | 30 Sep 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.62%
|
767,229
|
$15,252,513 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.58%
|
714,351
|
$14,201,296 | — | 30 Sep 2024 | |
| JUPITER ASSET MANAGEMENT LTD |
13F
|
Company |
0.57%
|
699,944
|
$13,914,886 | — | 30 Sep 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.54%
|
667,240
|
$13,264,731 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.53%
|
654,948
|
$13,020,366 | — | 30 Sep 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.47%
|
578,208
|
$11,494,775 | — | 30 Sep 2024 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.47%
|
575,953
|
$11,449,945 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.45%
|
559,767
|
$11,128,168 | — | 30 Sep 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.37%
|
459,352
|
$9,131,918 | — | 30 Sep 2024 | |
| OBERWEIS ASSET MANAGEMENT INC/ |
13F
|
Company |
0.37%
|
458,400
|
$9,112,992 | — | 30 Sep 2024 | |
| GABLES CAPITAL MANAGEMENT INC. |
13F
|
Company |
0.35%
|
427,251
|
$8,493,749 | — | 30 Sep 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.34%
|
424,899
|
$8,446,992 | — | 30 Sep 2024 | |
| Skandinaviska Enskilda Banken AB (publ) |
13F
|
Company |
0.34%
|
419,900
|
$8,347,612 | — | 30 Sep 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.34%
|
417,850
|
$8,306,858 | — | 30 Sep 2024 | |
| JW Asset Management, LLC |
13F
|
Company |
0.34%
|
413,392
|
$8,218,233 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.33%
|
408,261
|
$8,116,228 | — | 30 Sep 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.33%
|
401,908
|
$7,989,931 | — | 30 Sep 2024 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.32%
|
400,000
|
$7,952,000 | — | 30 Sep 2024 | |
| Brandywine Global Investment Management, LLC |
13F
|
Company |
0.32%
|
392,118
|
$8,093,316 | — | 30 Sep 2024 | |
| Altium Capital Management LLC |
13F
|
Company |
0.31%
|
385,000
|
$7,653,800 | — | 30 Sep 2024 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.3%
|
366,444
|
$7,284,906 | — | 30 Sep 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.29%
|
360,191
|
$7,160,383 | — | 30 Sep 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.27%
|
326,446
|
$6,489,747 | — | 30 Sep 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.25%
|
311,368
|
$6,189,975 | — | 30 Sep 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.25%
|
306,458
|
$6,092,385 | — | 30 Sep 2024 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.24%
|
301,646
|
$5,996,722 | — | 30 Sep 2024 |
Institutional Holders of CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) as of Q4 2024
As of 31 Dec 2024,
CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) was held by
333 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
97,462,582 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), DIMENSIONAL FUND ADVISORS LP, Pacer Advisors, Inc., GOLDMAN SACHS GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, and FIRST TRUST ADVISORS LP.
This page lists
335
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
312
Q4 2024 holders
333
Holder diff
21
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.